|
|
Early blood pressure alterations are associated with pro-inflammatory markers in type 1 diabetes mellitus
|
|
|
|
|
نویسنده
|
Mateo-Gavira I ,Vílchez-López F J ,García-Palacios M V ,Laureano F Carral-San ,Visiedo-García F M ,Aguilar-Diosdado M
|
منبع
|
journal of human hypertension - 2017 - دوره : 31 - شماره : 2 - صفحه:151 -156
|
چکیده
|
The aim of this study was to evaluate the relationship between early blood pressure (bp) changes (detected using ambulatory bp monitoring; abpm) with different markers of inflammation and endothelial dysfunction in patients with type 1 diabetes mellitus (t1dm). the study design was observational cross-sectional in 85 t1dm patients, clinically normotensive and with normo-albuminuria. we analyzed the relationships between abpm-measured bp alterations over 24 h with the inflammatory cytokines (interleukin-6 (il-6), tumor necrosis factor-α and vascular endothelial growth factor (vegf)) and the markers of endothelial damage (vascular adhesion molecule, intercellular adhesion molecule and plasminogen activator inhibitor-1 (pai)). despite being recorded as normotensive, 27 (31.8%) subjects presented with an average of pathological bp. vegf levels were significantly elevated in the patients with an altered mean diurnal values compared with normotensives (112.33 (72.87–213.53) pg ml−1 vs 71.03 (37.71–107.92) pg ml−1; p=0.007). further, vegf levels correlated significantly with the parameters of diurnal bp and of 24 h values. il-6 concentration was a risk factor in the patients with hypertension (or=1.406; p=0.027). there were no modifications in the levels of markers of endothelial damage. summarizing, there is an increase in pro-inflammatory cytokines, but not the endothelial adhesion molecules, in early stages of arterial hypertension in patients with t1dm.
|
|
|
آدرس
|
Puerta del Mar Hospital, Department of Endocrinology, Spain, Puerta del Mar Hospital, Department of Endocrinology, Spain, Puerta del Mar Hospital, Department of Preventive Medicine and Public Health, Spain, Puerto Real Hospital, Department of Endocrinology, Spain, Puerta del Mar Hospital, Department of Investigation, Spain, Puerta del Mar Hospital, Department of Endocrinology and Investigation Unit, Spain
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|